PLRX
Pliant Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.16
+2.65%Aug 11, 2026, 20:05 UTC
Pliant Therapeutics appointed Flavia Borellini, Ph.D. and Robert Iannone, M.D. as seasoned oncology drug development leaders.
Source:Jul 13, 2026, 12:30 UTC
Pliant Therapeutics appointed Flavia Borellini and Robert Iannone to its board of directors.
Source: